TABLE 1.
Quantification of early and late apoptotic TIGK cells from Fig. 5C
| Treatment | Concn (μM) | Live cells (%) | Early apoptosis (%) | Late apoptosis/necrosis (%)a |
|---|---|---|---|---|
| Medium | 92.7 | 2.6 | 2.7 | |
| Medium/DMSO | 91.3 | 1.4 | 3.9 | |
| Medium/H2O2 | 56.6 | 4.9 | 21.9* | |
| N17 | 5 | 90.7 | 2.9 | 4.2 |
| 20 | 92.4 | 2.4 | 3.6 | |
| 40 | 91.6 | 1.5 | 5.1 | |
| V8 | 5 | 91.6 | 3.1 | 4.2 |
| 20 | 92.8 | 2.1 | 3.5 | |
| 40 | 92.8 | 2.4 | 3.4 | |
| N7 | 5 | 86.8 | 2.4 | 8.3 |
| 20 | 74.5 | 1.0 | 14.9* | |
| 40 | 48.3 | 5.9 | 40.7* |
a
Asterisks indicate a significant increase (P < 0.001) in apoptotic cells relative to the medium and medium/DMSO controls.